• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • AB Science – Masitinib
      • BrainStorm Cell Therapeutics – NurOwn
      • Clene Nanomedicine – CNM-Au8
      • ILB – Tikomed
      • Kadimastem – AstroRx
      • Mitsubishi Tanabe Pharma America – Oral Edaravone
      • Neuronata-R/Lenzumestrocel
      • NeuroSense – PrimeC
      • Neuvivo – NP001
      • Prilenia Therapeutics – Pridopidine
      • SOD1 Therapies & Trials
      • SPG302
      • T Regulatory Cell Therapies
      • Ulefnersen – Ionis Pharmaceuticals
    • Approved Drugs
      • Nuedexta
      • Radicava/Edaravone
      • Riluzole/Tiglutik
      • Rozebalamin/Methylcobalamin
      • Tofersen/Qalsody
    • Drugs No Longer in Development
      • Amylyx – AMX0035
      • Collaborative Medicinal Development – CuATSM
      • Cytokinetics – Reldesemtiv
      • Orphazyme – Arimoclomol
      • TUDCA Trial
  • Support for Health Professionals
    • Breaking the News in ALS/MND
  • Events/Programs
    • Calendar of Events/Programs
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • International Symposium
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

Forum Guidelines

International Alliance of ALS/MND Associations › Forums › Member Forum › Forum Guidelines

  • This topic has 0 replies, 1 voice, and was last updated 9 years, 10 months ago by Admin.
Viewing 1 post (of 1 total)
  • Author
    Posts
  • August 15, 2016 at 9:48 am #2059
    Admin
    Keymaster

      While writing on the forum, we expect all members to treat one another with respect, even if we may disagree. Our Executive Director will moderate the forum to the best of her ability. Please alert Cathy (alliance@als-mnd.org) if anyone is misusing the forum. We hope this is a wonderful resource for all of our members.

      • This topic was modified 6 years, 3 months ago by International Alliance.
      • This topic was modified 6 years, 3 months ago by Admin.
    • Author
      Posts
    Viewing 1 post (of 1 total)
    • You must be logged in to reply to this topic.
    Log In

    Primary Sidebar

    • Lachlan Terry, Australia

      Lachlan Terry, Australia

    • Rosie Riley, USA

      Rosie Riley, USA

    • Magdalena Ayala Rodríguez, Mexico

      Magdalena Ayala Rodríguez, Mexico

    • Brigitte Wernli, Switzerland

      Brigitte Wernli, Switzerland

    • Frank Bos, Netherlands

      Frank Bos, Netherlands

    • Wilfried Leusing, Germany

      Wilfried Leusing, Germany

    • Hiroshi Matsuyama, Japan

      Hiroshi Matsuyama, Japan

    • Amparo Muriel Engativa, Colombia

      Amparo Muriel Engativa, Colombia

    • Natalya Rybakova, Russia

      Natalya Rybakova, Russia

    • Danny Reviers, Belgium

      Danny Reviers, Belgium
      DannyReviers

    • Jan Zuring, Netherlands

      Jan Zuring, Netherlands

    • Art Eggert, USA

      Art Eggert, USA

    • Alejandro Aquino, Argentina

      Alejandro Aquino, Argentina

    • Natalya Rybakova, Russia

      Natalya Rybakova, Russia

    • Mauril Bélanger, Canada

      Mauril Bélanger, Canada

    • Dorette Lüdi, Switzerland

      Dorette Lüdi, Switzerland

    • David Hall, USA

      David Hall, USA

    • Diana Fernandez, Argentina

      Diana Fernandez, Argentina

    • Wilfried Leusing, Germany

      Wilfried Leusing, Germany

    • Shera Mukherjee, India

      Shera Mukherjee, India

    • Rolf Mauch, Switzerland

      Rolf Mauch, Switzerland

    • Robbie Caliste, UK

      Robbie Caliste, UK

    • Hanne Stenmose, Denmark

      Hanne Stenmose, Denmark

    • Steve Gallagher, Canada

      Steve Gallagher, Canada
      Picture1

    • Kirsty Gerlach, New Zealand

      Kirsty Gerlach, New Zealand

    • Fabio Correia, Brazil

      Fabio Correia, Brazil

    • Antonio Ventriglia, Belgium

      Antonio Ventriglia, Belgium

    • Charlie Dourney, USA

      Charlie Dourney, USA

    • Angela Jansen, Germany

      Angela Jansen, Germany

    • Brian Lovell, Australia

      Brian Lovell, Australia

    • Orlando Ruiz, Colombia

      Orlando Ruiz, Colombia

    • Lineke Veenstra, Netherlands

      Lineke Veenstra, Netherlands

    • Jon Newsome, USA

      Jon Newsome, USA

    • Maria Lucia Wood Saldanha, Brazil

      Maria Lucia Wood Saldanha, Brazil

    • Lee Millard, England

      Lee Millard, England

    • Daniel Hare, USA

      Daniel Hare, USA

    • Shay Rishoni, Israel

      Shay Rishoni, Israel

    • Ismail Gokcek, Turkey

      Ismail Gokcek, Turkey
      ismail_gokcek_alsmnd_tr

    • Cliff Marshman, USA

      Cliff Marshman, USA
      CliffMarshman

    • Zabun Nassar, England

      Zabun Nassar, England

    • Gudjon Sigurdsson, Iceland

      Gudjon Sigurdsson, Iceland

    • Lucy Lintott, Scotland

      Lucy Lintott, Scotland

    • Calum Ferguson, Scotland

      Calum Ferguson, Scotland

    • Ian Roberts, Australia

      Ian Roberts, Australia

    • Laurie Petit-Jean, France

      Laurie Petit-Jean, France

    • Alfredo Santos, Colombia

      Alfredo Santos, Colombia

    • Steve

      Steve

    • Chen Yin Xue, Taiwan

      Chen Yin Xue, Taiwan

    • Jorge Melo, Brazil

      Jorge Melo, Brazil

    • Joanne Pratt, Australia

      Joanne Pratt, Australia

    Learn more about the March of Faces

    Footer

    Stay connected to the global ALS/MND community.

    Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

     
    This field is for validation purposes and should be left unchanged.
    • Email
    • Facebook
    • LinkedIn
    • Twitter
    • YouTube
    Return to top of page

    Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

    Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


    Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login